104 related articles for article (PubMed ID: 2223007)
21. Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemia.
Berrebi A; Shtalrid M; Klepfish A; Bassous L; Kushnir M; Shulman L; Vorst E; Hahn T
Leukemia; 1994 Dec; 8(12):2214-6. PubMed ID: 7808009
[TBL] [Abstract][Full Text] [Related]
22. [Functional properties of B-lymphocytes of patients with a B-cell variant of chronic lymphocytic leukemia and chronic glomerulonephritis].
Ostanin AA; Chernykh ER; Shubinskiĭ GZ; Nekipelova VI; Tov NL; Lozovoĭ VP
Vestn Akad Med Nauk SSSR; 1991; (12):19-23. PubMed ID: 1801468
[TBL] [Abstract][Full Text] [Related]
23. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
[TBL] [Abstract][Full Text] [Related]
24. Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia.
Hebenstreit K; Iacobelli S; Leiblein S; Eisfeld AK; Pfrepper C; Heyn S; Vucinic V; Franke GN; Krahl R; Fricke S; Becker C; Pönisch W; Behre G; Niederwieser D; Lange T
Leuk Lymphoma; 2014 Jun; 55(6):1274-80. PubMed ID: 23964650
[TBL] [Abstract][Full Text] [Related]
25. Colony-stimulating factors in B-cell colony formation in patients with B-cell chronic lymphocytic leukemia.
Ishiyama T; Abe S; Wakabayashi Y; Hirose S
Acta Haematol; 1989; 81(1):10-4. PubMed ID: 2494829
[TBL] [Abstract][Full Text] [Related]
26. Abnormal distribution of CD8 subpopulation in B-chronic lymphocytic leukemia identified by flow cytometry.
Terstappen LW; de Grooth BG; van Berkel W; ten Napel CH; Greve J
Leuk Res; 1988; 12(7):551-7. PubMed ID: 2459562
[TBL] [Abstract][Full Text] [Related]
27. Prognostic evaluation of specific cutaneous infiltrates in B-chronic lymphocytic leukemia.
Kaddu S; Smolle J; Cerroni L; Kerl H
J Cutan Pathol; 1996 Dec; 23(6):487-94. PubMed ID: 9001978
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia.
Sarfati M; Fournier S; Christoffersen M; Biron G
Leuk Res; 1990; 14(1):47-55. PubMed ID: 2137545
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
Cordone I; Matutes E; Catovsky D
Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
[TBL] [Abstract][Full Text] [Related]
30. Impaired transendothelial migration of B-CLL lymphocytes: a defect linked to low L-selectin expression.
Gu B; Dao LP; Wiley J
Leuk Lymphoma; 2001 Jun; 42(1-2):5-12. PubMed ID: 11699221
[TBL] [Abstract][Full Text] [Related]
31. Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in normal and chronic lymphocytic leukemia lymphocytes.
Scher NS; Quagliata F; Malathi VG; Faig D; Melton RA; Silber R
Cancer Res; 1976 Nov; 36(11 Pt 1):3958-62. PubMed ID: 184920
[TBL] [Abstract][Full Text] [Related]
32. The sensitivity of chronic lymphocytic leukaemia lymphocytes to irradiation in vitro.
Bentley P; Salter R; Blackmore J; Whittaker JA; Hanson JA; Champion AR
Leuk Res; 1995 Dec; 19(12):985-8. PubMed ID: 8632669
[TBL] [Abstract][Full Text] [Related]
33. Selective toxicity of ethacrynic acid towards lymphocytes of chronic lymphocytic leukemia in vitro.
Twentyman PR; Lambert E; Müller M; Rees JK
Leukemia; 1992 Jul; 6(7):726-8. PubMed ID: 1625494
[TBL] [Abstract][Full Text] [Related]
34. Chronic B-lymphocytic leukemia--expression of B cell activation markers in relation to activity of the disease.
Tötterman TH; Carlsson M; Funderud S; Simonsson B; Oberg G; Nilsson K
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):279-81. PubMed ID: 3265498
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia.
Orfao A; Ciudad J; González M; San Miguel JF; García AR; López-Berges MC; Ramos F; Del Cañizo MC; Ríos A; Sanz M
Leukemia; 1992 Jan; 6(1):47-51. PubMed ID: 1736013
[TBL] [Abstract][Full Text] [Related]
36. The pathogenesis of chronic lymphocytic leukemia.
Galton DA
Can Med Assoc J; 1966 May; 94(19):1005-10. PubMed ID: 4952384
[TBL] [Abstract][Full Text] [Related]
37. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
Karray S; Emilie D; Galanaud P
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
[TBL] [Abstract][Full Text] [Related]
38. Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia.
Maďarová M; Mucha R; Hresko S; Makarová Z; Gdovinová Z; Szilasiová J; Vitková M; Guman T; Štecová N; Dobransky T
Leuk Res; 2018 Jul; 70():25-33. PubMed ID: 29763855
[TBL] [Abstract][Full Text] [Related]
39. Short-term growth potential of cryopreserved B chronic lymphocytic leukemia cells in suspension and in semisolid medium.
Vilpo J; Vilpo L
Leukemia; 2001 Jun; 15(6):992-4. PubMed ID: 11417491
[No Abstract] [Full Text] [Related]
40. Feasibility of Counting Smudge Cells as Lymphocytes in Differential Leukocyte Counts Performed on Blood Smears of Patients With Established or Suspected Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Gulati G; Ly V; Uppal G; Gong J
Lab Med; 2017 May; 48(2):137-147. PubMed ID: 28371883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
